Keywords: biolipox, completes, phase, novel, hay, fever, treatment

Biolipox completes Phase I for novel hay fever treatment

Article | 28 February 2005

The Swedish respiratory health care specialist drugmaker Biolipox has successfully completed an initial clinical study for its new antihistamine nasal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Mometasone Furoate

Flunisolide

Nasal Spray

Go to drug listing